IMNM
Price
$9.06
Change
+$0.30 (+3.42%)
Updated
Jun 2 closing price
Capitalization
788.33M
71 days until earnings call
SYRE
Price
$15.68
Change
+$0.28 (+1.82%)
Updated
Jun 3, 10:40 AM (EDT)
Capitalization
929.44M
58 days until earnings call
Interact to see
Advertisement

IMNM vs SYRE

Header iconIMNM vs SYRE Comparison
Open Charts IMNM vs SYREBanner chart's image
Immunome
Price$9.06
Change+$0.30 (+3.42%)
Volume$688.68K
Capitalization788.33M
Spyre Therapeutics
Price$15.68
Change+$0.28 (+1.82%)
Volume$795
Capitalization929.44M
IMNM vs SYRE Comparison Chart
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. SYRE commentary
Jun 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a StrongBuy and SYRE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2025
Stock price -- (IMNM: $9.06 vs. SYRE: $15.40)
Brand notoriety: IMNM and SYRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 59% vs. SYRE: 58%
Market capitalization -- IMNM: $788.33M vs. SYRE: $929.44M
IMNM [@Biotechnology] is valued at $788.33M. SYRE’s [@Biotechnology] market capitalization is $929.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $307.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileSYRE’s FA Score has 0 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • SYRE’s FA Score: 0 green, 5 red.
According to our system of comparison, IMNM is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 7 TA indicator(s) are bullish while SYRE’s TA Score has 4 bullish TA indicator(s).

  • IMNM’s TA Score: 7 bullish, 3 bearish.
  • SYRE’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than SYRE.

Price Growth

IMNM (@Biotechnology) experienced а +6.71% price change this week, while SYRE (@Biotechnology) price change was +2.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.46%. For the same industry, the average monthly price growth was +5.51%, and the average quarterly price growth was +2.02%.

Reported Earning Dates

IMNM is expected to report earnings on Aug 13, 2025.

SYRE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+8.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYRE($929M) has a higher market cap than IMNM($788M). IMNM YTD gains are higher at: -14.689 vs. SYRE (-33.849). IMNM has higher annual earnings (EBITDA): -109.95M vs. SYRE (-214.36M). SYRE has more cash in the bank: 565M vs. IMNM (240M). SYRE has less debt than IMNM: SYRE (0) vs IMNM (2.72M). IMNM has higher revenues than SYRE: IMNM (10.1M) vs SYRE (0).
IMNMSYREIMNM / SYRE
Capitalization788M929M85%
EBITDA-109.95M-214.36M51%
Gain YTD-14.689-33.84943%
P/E RatioN/A1.72-
Revenue10.1M0-
Total Cash240M565M42%
Total Debt2.72M0-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
9

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMNMSYRE
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 28 days ago
87%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVFIX4.28N/A
N/A
Federated Hermes Intl Strat Val Div IS
MUXAX25.69N/A
N/A
Victory S&P 500 Index A
DDVIX13.53N/A
N/A
Macquarie Value Inst
FNKLX15.80N/A
N/A
Fidelity Series Value Discovery
AOPAX32.40N/A
N/A
Virtus International S/C A

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
+3.42%
IDYA - IMNM
59%
Loosely correlated
+6.69%
BEAM - IMNM
55%
Loosely correlated
+2.27%
RXRX - IMNM
55%
Loosely correlated
+4.55%
SYRE - IMNM
54%
Loosely correlated
+0.79%
TRDA - IMNM
52%
Loosely correlated
+7.11%
More

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with BEAM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
+0.79%
BEAM - SYRE
58%
Loosely correlated
+2.27%
CGON - SYRE
57%
Loosely correlated
+3.79%
IMNM - SYRE
53%
Loosely correlated
+3.42%
APGE - SYRE
53%
Loosely correlated
-0.85%
XNCR - SYRE
53%
Loosely correlated
+7.25%
More